New Key Statistics Module, Z-Score and F-Score
NYSE:BMY Key Ratios
Market Cap $ M | 90,631.65 |
Enterprise Value $ M | 139,080.13 |
P/E(ttm) | -- |
PE Ratio without NRI | 42.58 |
Forward PE Ratio | 84.10 |
Price/Book | 5.49 |
Price/Sales | 2.03 |
Price/Free Cash Flow | 7.32 |
Price/Owner Earnings | -- |
Payout Ratio % | 2.23 |
Revenue (TTM) $ M | 45,534.00 |
EPS (TTM) $ | -3.10 |
Beneish M-Score | -2.92 |
10-y EBITDA Growth Rate % | 17.30 |
5-y EBITDA Growth Rate % | 24.50 |
y-y EBITDA Growth Rate % | -73.60 |
EV-to-EBIT | -30.61 |
EV-to-EBITDA | 26.14 |
PEG | 1.74 |
Shares Outstanding M | 2,027.10 |
Net Margin (%) | -13.50 |
Operating Margin % | 15.98 |
Pre-tax Margin (%) | -12.84 |
Quick Ratio | 0.99 |
Current Ratio | 1.11 |
ROA % (ttm) | -6.50 |
ROE % (ttm) | -22.16 |
ROIC % (ttm) | 9.31 |
Dividend Yield % | 5.24 |
Altman Z-Score | 1.23 |
BMY Number of Guru Trades
BMY Volume of Guru Trades
Gurus Latest Trades with NYSE:BMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:BMY is held by these investors
Total 11
Bristol-Myers Squibb Co Insider Transactions
No Available Data
News about NYSE:BMY
Total 0- 1